• Company
• Severe asthma treatment Fasenra seeks reimb in KOR
• by Eo, Yun-Ho Dec 19, 2022 04:34am

• Policy
• MFDS approves Jemperil, the third PD-1 inhibitor in Korea
• by Lee, Hye-Kyung Dec 15, 2022 05:55am

• Company
• Asthma treatment Cinqair attempts reimb again in Korea
• by Eo, Yun-Ho Dec 15, 2022 05:55am

• Company
• Verzenio expects to address the unmet demand
• by Eo, Yun-Ho Dec 15, 2022 05:55am

• Product
• Menarini Korea is expected to distribute Viagra
• by Kim JiEun Dec 15, 2022 05:55am

• Policy
• MFDS “Increasing AAP manufacturing well in progress”
• by Lee, Hye-Kyung Dec 14, 2022 05:57am

• Company
• Samsung Epis's Soliris biosimilar bioequivalent to original
• by Dec 14, 2022 05:56am

• Company
• Champix supply interruption
• by Kim, Jin-Gu Dec 14, 2022 05:56am

• Company
• 2022 Pharmaceutical Industry Advertising Target Call Members
• by Dec 14, 2022 05:56am

• Policy
• $25.5 billion in exports to the health industry
• by Kim, Jung-Ju Dec 14, 2022 05:56am